These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38879998)

  • 1. A review on revolutionizing ophthalmic therapy: Unveiling the potential of chitosan, hyaluronic acid, cellulose, cyclodextrin, and poloxamer in eye disease treatments.
    Wang TJ; Rethi L; Ku MY; Nguyen HT; Chuang AE
    Int J Biol Macromol; 2024 Jul; 273(Pt 2):132700. PubMed ID: 38879998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
    Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
    Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid in ocular drug delivery.
    Zhang X; Wei D; Xu Y; Zhu Q
    Carbohydr Polym; 2021 Jul; 264():118006. PubMed ID: 33910737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision.
    Biswas A; Kumar S; Choudhury AD; Bisen AC; Sanap SN; Agrawal S; Mishra A; Verma SK; Kumar M; Bhatta RS
    Biopolymers; 2024 Jul; 115(4):e23578. PubMed ID: 38577865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
    Jansook P; Pichayakorn W; Muankaew C; Loftsson T
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate polymer-based bioadhesive formulations and their potentials for the treatment of ocular diseases: A review.
    Tang X; Liu J; Yan R; Peng Q
    Int J Biol Macromol; 2023 Jul; 242(Pt 3):124902. PubMed ID: 37210054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on topical ophthalmic drug delivery system: Reference to viscosity enhancer.
    Pawar PK; Rathod RD; Jagadale SR
    Polim Med; 2024; 54(1):71-84. PubMed ID: 38533624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-Cyclodextrin-based polypseudorotaxane hydrogels for ophthalmic delivery of flurbiprofen to treat anterior uveitis.
    Fang G; Wang Q; Yang X; Qian Y; Zhang G; Tang B
    Carbohydr Polym; 2022 Feb; 277():118889. PubMed ID: 34893291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ gel systems as 'smart' carriers for sustained ocular drug delivery.
    Agrawal AK; Das M; Jain S
    Expert Opin Drug Deliv; 2012 Apr; 9(4):383-402. PubMed ID: 22432690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview.
    Almeida H; Amaral MH; Lobão P; Sousa Lobo JM
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1223-37. PubMed ID: 23688342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight on updates in polysaccharides for ocular drug delivery.
    Chandra NS; Gorantla S; Priya S; Singhvi G
    Carbohydr Polym; 2022 Dec; 297():120014. PubMed ID: 36184137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
    Mandal A; Bisht R; Rupenthal ID; Mitra AK
    J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular application of chitosan.
    Başaran E; Yazan Y
    Expert Opin Drug Deliv; 2012 Jun; 9(6):701-12. PubMed ID: 22530690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
    Shree D; Patra CN; Sahoo BM
    Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cellulose nanocrystals on the performance of drug loaded in situ gelling thermo-responsive ophthalmic formulations.
    Orasugh JT; Sarkar G; Saha NR; Das B; Bhattacharyya A; Das S; Mishra R; Roy I; Chattoapadhyay A; Ghosh SK; Chattopadhyay D
    Int J Biol Macromol; 2019 Mar; 124():235-245. PubMed ID: 30481535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmic nano-bioconjugates: critical challenges and technological advances.
    Sanap SN; Bisen AC; Agrawal S; Kedar A; Bhatta RS
    Ther Deliv; 2023 Jul; 14(7):419-441. PubMed ID: 37535389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New nanoparticles for topical ocular delivery of erythropoietin.
    Silva B; Marto J; Braz BS; Delgado E; Almeida AJ; Gonçalves L
    Int J Pharm; 2020 Feb; 576():119020. PubMed ID: 31935477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.